XGN - Exagen Inc
IEX Last Trade
2.96
-0.030 -1.014%
Share volume: 19,413
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$2.99
-0.03
-1.00%
Summary score
22%
Profitability
18%
Dept financing
14%
Liquidity
73%
Performance
16%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-14.82%
Return on assets
-6.93%
Return on sales
-55.97%
Return on invested capital
-263.6%
Total debt ratio
43.78%
Debt ratio change over timeo
-1.09%
Current Ratio
9.17%
Quick Ratio
8.93%
Cash Position Ratio
7.72%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-19.19%
Return on assets
-7.73%
Return on sales
-32.69%
Return on invested capital
173.45%
Total debt ratio
56.49%
Debt ratio change over timeo
-0.92%
Current Ratio
4.91%
Quick Ratio
4.91%
Cash Position Ratio
3.16%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-16.81%
Return on assets
-5.91%
Return on sales
-20.83%
Return on invested capital
896%
Total debt ratio
60.65%
Debt ratio change over time
-0.7%
Current Ratio
4.83%
Quick Ratio
4.83%
Cash Position Ratio
3.1%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-95.68%
Return on assets
-97.79%
Return on sales
-75.69%
Return on invested capital
28.27%
Total debt ratio
-108.89%
Debt ratio change over time
-1.09%
Current Ratio
-3.29%
Quick Ratio
-3.48%
Cash Position Ratio
-3%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | XGN | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -14.82% | 13.79% | 34.47% | 7.43% |
| Return on assets | -6.93% | 2.76% | 3.15% | 5.62% |
| Return on sales | -55.97% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | -263.6% | 2.36% | 5.39% | 19.77% |
| Profitability | 0% | 43% | 66% | 80% |
| Total debt ratio | 43.78% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -1.09% | 308.97% | -6.99% | 1.18% |
| Dept financing | 12% | 50% | 25% | 7% |
| Current Ratio | 4.91% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 4.91% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 3.16% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 6% | 13% | 29% |
| Short-term ratios | XGN | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -19.19% | 13.77% | 13.25% | 3.8% |
| Return on assets | -7.73% | 2.43% | 1.89% | 3.09% |
| Return on sales | -32.69% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 173.45% | 2.14% | 3.39% | 9.18% |
| Profitability | 25% | 65% | 59% | 58% |
| Total debt ratio | 56.49% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -0.92% | 46.38% | -72.08% | 1.51% |
| Dept financing | 15% | 50% | 25% | 7% |
| Current Ratio | 4.91% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 4.91% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 3.16% | 0.36% | 1.28% | 2.93% |
| Liquididy | 73% | 11% | 29% | 72% |